News Center

Home page

Peak Report

News reports

Shanghai North Carolina and Jiangsu Jiuyang Reach Strategic Cooperation

Release time:

2020-07-22

Shanghai North Carolina and Jiangsu Jiuyang Reach Strategic Cooperation

News from our newspaper 11# July 18 , Shanghai North Carolina Pharmaceutical Technology Co., Ltd. formally reached strategic cooperation with Jiangsu Jiuyang Biopharmaceutical Co., Ltd. (hereinafter referred to as Jiangsu Jiuyang), a subsidiary of Hangzhou Sino-US East China Pharmaceutical Co., Ltd, in the next 3 years, the two sides will carry out in-depth cooperation and exchanges in the development of variety technology, process improvement, quality improvement and supply of key starting materials. Kang Litao, general manager of Shanghai North Carolina, and Li Qian, deputy general manager, attended the signing ceremony.

Jiangsu Jiuyang was established in 2007 3 , 2011 8 and realized asset reorganization with East China Pharmaceutical Co., Ltd. and became a holding subsidiary of East China Pharmaceutical Co., Ltd.

As the first enterprise to reach a strategic cooperation with Shanghai North Carolina, Jiangsu Jiuyang has already started project cooperation with Shanghai North Carolina in 2017 . The successful cooperation in capecitabine and tinib products is the basis for the strategic cooperation between the two sides. At the signing ceremony, Kang Litao reviewed the project cooperation between the two sides during 2 and expressed his recognition of the future development potential. In view of the planning of future strategic cooperation, Kang Litao said that Shanghai Beika and its three subsidiaries have been committed to building a green pharmaceutical platform for high-end APIs and advanced intermediates, improving internal skills in cooperation, and creating more high-quality, reliable and competitive varieties of advanced APIs and intermediates to be shared with partners. (Li Yimin)

More information

2022 China's Top 100 Building Materials Enterprises 2022 China's Top 100 Cement Clinker Production Capacity Peak even on two authoritative lists

In March, the authoritative organization of the cement industry successively released two series of lists of China's top 500 building materials enterprises in 2022 and China's top 100 cement clinker production capacity in 2022. Jianfeng Group ranked among the "top 100" in the two lists ". The list of China's top 500 building materials enterprises was officially released in early March. This series of lists was selected by the China Building Materials Enterprise Management Association. Through more than 20 years of comprehensive data research on China's building materials industry, referring to international practices, the rankings are based on the company's annual operating income., Cement products, building ceramics, waterproof materials, aluminum-plastic profiles, coatings, glass, building materials equipment manufacturing and other sub-industries related to building materials. Jianfeng Group ranks 96th among the companies on the list and 27th among the cement manufacturers on the list. On March 16, the awarding ceremony of 2022 China's top 100 cement clinker production capacity list was held in Hangzhou. This series of lists is released by China Cement Network, an authoritative organization in China's cement industry. The ranking is based on the total production capacity (excluding the production capacity of other kiln types and grinding stations) of new dry clinker production lines completed and put into operation by Chinese cement enterprises in China as of December 31, 2022. The data statistics are calculated based on the design production capacity and 310 days of annual operation. Jianfeng Group ranked 53rd with an annual design capacity of 3.627 million tons. (this newspaper reporter)

2023

03-21

Company sends off retired employees

On the morning of February 22, the trade union of the group company held a simple and warm farewell party for retired employees in 2021-2022. More than 50 retired employees gathered together to discuss and exchange with Jiang Xiaomeng and other group leaders.

2023

03-04

On the first day of the new year, group leaders went to the grassroots level.

On January 29, the first day of work after the Spring Festival holiday, the leaders of the group company made a video connection to subordinate enterprises stationed abroad, and separately visited the gold enterprises to learn about the resumption of work and put forward requirements for the implementation of the work plan for the new year.

2023

02-17

Group Companies Commend 2022 Advanced

On the morning of January 18, the group company held the 2022 annual summary commendation meeting to review the work of the previous year, make arrangements for the work in 2023, sign the 2023 economic responsibility system with various professional companies and directly affiliated enterprises, and solemnly commend the 2022 advanced collectives and individuals.

2023

01-29

Jiang Xiaomeng re-elected chairman of the Municipal Federation of Industry and Commerce

On December 24, 2022, the Jinhua Federation of Industry and Commerce (General Chamber of Commerce) held the seventh member representative meeting. Jiang Xiaomeng, secretary of the party committee and chairman of the group company, was re-elected as the chairman of the Municipal Federation of Industry and Commerce at this meeting.

2023

01-12

Peak Pharmaceutical Donates Epidemic Prevention Materials

Since the optimization and adjustment of the new crown infection epidemic management policy, there has been an explosive growth of infected people in the country, and the pressure on the supply of related materials has increased sharply. Before and after New Year's Day, the company has twice organized epidemic prevention materials, through the Jinhua City Charity Federation, Jinhua City Economic and Technological Development Zone Charity Federation targeted donations, a total value of more than 200,000 yuan.

2023

01-12

< 1 2 3 4...61 > 跳转到页